vs

Side-by-side financial comparison of Axogen, Inc. (AXGN) and Cheer Holding, Inc. (CHR). Click either name above to swap in a different company.

Cheer Holding, Inc. is the larger business by last-quarter revenue ($71.0M vs $61.5M, roughly 1.2× Axogen, Inc.). Cheer Holding, Inc. runs the higher net margin — 10.9% vs -31.9%, a 42.8% gap on every dollar of revenue. On growth, Axogen, Inc. posted the faster year-over-year revenue change (26.6% vs -0.1%).

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering (IPO). Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is...

Cheer Holding, Inc. is a diversified holding company primarily operating in the Chinese market, with core business segments covering early childhood education services, mobile lifestyle platforms, digital content offerings, and integrated consumer solutions for households and enterprise partners across multiple demand scenarios.

AXGN vs CHR — Head-to-Head

Bigger by revenue
CHR
CHR
1.2× larger
CHR
$71.0M
$61.5M
AXGN
Growing faster (revenue YoY)
AXGN
AXGN
+26.6% gap
AXGN
26.6%
-0.1%
CHR
Higher net margin
CHR
CHR
42.8% more per $
CHR
10.9%
-31.9%
AXGN

Income Statement — Q1 FY2026 vs Q2 FY2025

Metric
AXGN
AXGN
CHR
CHR
Revenue
$61.5M
$71.0M
Net Profit
$-19.6M
$7.8M
Gross Margin
75.2%
70.7%
Operating Margin
11.7%
Net Margin
-31.9%
10.9%
Revenue YoY
26.6%
-0.1%
Net Profit YoY
-410.8%
-37.5%
EPS (diluted)
$-0.38
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXGN
AXGN
CHR
CHR
Q1 26
$61.5M
Q4 25
$59.9M
Q3 25
$60.1M
Q2 25
$56.7M
$71.0M
Q1 25
$48.6M
Q4 24
$49.4M
Q3 24
$48.6M
Q2 24
$47.9M
$71.1M
Net Profit
AXGN
AXGN
CHR
CHR
Q1 26
$-19.6M
Q4 25
$-13.2M
Q3 25
$708.0K
Q2 25
$579.0K
$7.8M
Q1 25
$-3.8M
Q4 24
$450.0K
Q3 24
$-1.9M
Q2 24
$-1.9M
$12.4M
Gross Margin
AXGN
AXGN
CHR
CHR
Q1 26
75.2%
Q4 25
74.1%
Q3 25
76.6%
Q2 25
74.2%
70.7%
Q1 25
71.9%
Q4 24
76.1%
Q3 24
74.9%
Q2 24
73.8%
73.4%
Operating Margin
AXGN
AXGN
CHR
CHR
Q1 26
Q4 25
-16.3%
Q3 25
3.2%
Q2 25
3.0%
11.7%
Q1 25
-3.4%
Q4 24
4.1%
Q3 24
-0.6%
Q2 24
-0.9%
16.4%
Net Margin
AXGN
AXGN
CHR
CHR
Q1 26
-31.9%
Q4 25
-22.0%
Q3 25
1.2%
Q2 25
1.0%
10.9%
Q1 25
-7.9%
Q4 24
0.9%
Q3 24
-3.8%
Q2 24
-4.0%
17.5%
EPS (diluted)
AXGN
AXGN
CHR
CHR
Q1 26
$-0.38
Q4 25
$-0.28
Q3 25
$0.01
Q2 25
$0.01
$0.67
Q1 25
$-0.08
Q4 24
$-0.00
Q3 24
$-0.04
Q2 24
$-0.04
$1.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXGN
AXGN
CHR
CHR
Cash + ST InvestmentsLiquidity on hand
$82.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$244.8M
$322.1M
Total Assets
$289.5M
$362.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXGN
AXGN
CHR
CHR
Q1 26
$82.7M
Q4 25
$41.5M
Q3 25
$35.8M
Q2 25
$29.9M
Q1 25
$22.1M
Q4 24
$33.5M
Q3 24
$24.5M
Q2 24
$21.1M
$186.1M
Total Debt
AXGN
AXGN
CHR
CHR
Q1 26
Q4 25
$48.4M
Q3 25
$48.2M
Q2 25
$47.9M
Q1 25
$47.7M
Q4 24
$47.5M
Q3 24
$47.3M
Q2 24
$47.0M
Stockholders' Equity
AXGN
AXGN
CHR
CHR
Q1 26
$244.8M
Q4 25
$128.8M
Q3 25
$120.8M
Q2 25
$112.3M
$322.1M
Q1 25
$105.4M
Q4 24
$103.9M
Q3 24
$99.4M
Q2 24
$95.7M
$286.1M
Total Assets
AXGN
AXGN
CHR
CHR
Q1 26
$289.5M
Q4 25
$221.7M
Q3 25
$216.4M
Q2 25
$205.5M
$362.7M
Q1 25
$196.2M
Q4 24
$203.7M
Q3 24
$192.0M
Q2 24
$188.9M
$333.2M
Debt / Equity
AXGN
AXGN
CHR
CHR
Q1 26
Q4 25
0.38×
Q3 25
0.40×
Q2 25
0.43×
Q1 25
0.45×
Q4 24
0.46×
Q3 24
0.48×
Q2 24
0.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXGN
AXGN
CHR
CHR
Operating Cash FlowLast quarter
$3.9M
Free Cash FlowOCF − Capex
$-1.4M
FCF MarginFCF / Revenue
-2.3%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.51×
TTM Free Cash FlowTrailing 4 quarters
$9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXGN
AXGN
CHR
CHR
Q1 26
Q4 25
$3.0M
Q3 25
$3.2M
Q2 25
$7.7M
$3.9M
Q1 25
$-13.2M
Q4 24
$8.7M
Q3 24
$3.9M
Q2 24
$4.2M
$-6.7M
Free Cash Flow
AXGN
AXGN
CHR
CHR
Q1 26
$-1.4M
Q4 25
$1.8M
Q3 25
$1.7M
Q2 25
$7.0M
Q1 25
$-13.4M
Q4 24
$8.1M
Q3 24
$3.3M
Q2 24
$3.3M
FCF Margin
AXGN
AXGN
CHR
CHR
Q1 26
-2.3%
Q4 25
3.0%
Q3 25
2.8%
Q2 25
12.4%
Q1 25
-27.7%
Q4 24
16.3%
Q3 24
6.8%
Q2 24
6.8%
Capex Intensity
AXGN
AXGN
CHR
CHR
Q1 26
Q4 25
2.1%
Q3 25
2.5%
Q2 25
1.3%
Q1 25
0.5%
Q4 24
1.4%
Q3 24
1.2%
Q2 24
1.9%
Cash Conversion
AXGN
AXGN
CHR
CHR
Q1 26
Q4 25
Q3 25
4.55×
Q2 25
13.35×
0.51×
Q1 25
Q4 24
19.41×
Q3 24
Q2 24
-0.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons